Insights

Expanded drug approvals AstraZeneca recently secured accelerated FDA approvals for Ultomiris in IgA nephropathy, signaling a growing momentum in rare kidney disease treatments and potential for cross-sell with nephrology-focused services, digital health support, and payer navigation partnerships.

Renal disease focus Strong activity in kidney disease therapies (IgAN and other nephrology indications) presents opportunities to engage with nephrology clinics, hospital systems, and translational research partners seeking innovative care pathways and patient management solutions.

Clinical evidence momentum Continued positive Phase 3 and real-world data for Tezspire and related programs enhance AZN's appeal to specialty pharma channels, enabling co-marketing, advocacy alliances, and targeted clinical education collaborations.

Digital and tech readiness Adoption of Salesforce Lightning, Marketo, Oracle Eloqua, and Azure indicates a mature go-to-market engine, suggesting opportunities to offer sales enablement tooling, data enrichment, and digital patient engagement platforms to optimize launches.

Financial scale and partnerships Revenue in the billions with a substantial funding base and a broad employee footprint imply capability for large-scale partnerships, contract manufacturing, and joint venture discussions with CROs, biologics facilities, or regional distribution alliances.

Similar companies to AstraZeneca

AstraZeneca Tech Stack

AstraZeneca uses 8 technology products and services including Salesforce Lightning, Ansible, ChatGPT, and more. Explore AstraZeneca's tech stack below.

Media & News

AstraZeneca's Email Address Formats

AstraZeneca uses at least 5 email formats:
AstraZeneca Email FormatsExamplePercentage
First.Last@astrazeneca.comJohn.Doe@astrazeneca.com
91%
FirstLast@astrazeneca.comJohnDoe@astrazeneca.com
4%
First_Last@astrazeneca.comJohn_Doe@astrazeneca.com
4%
Last.First@astrazeneca.comDoe.John@astrazeneca.com
1%
FLast@zspharma.comJDoe@zspharma.com
100%

Frequently Asked Questions

What is AstraZeneca's phone number?

Minus sign iconPlus sign icon
You can contact AstraZeneca's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AstraZeneca's stock symbol?

Minus sign iconPlus sign icon
AstraZeneca is a publicly traded company; the company's stock symbol is AZN.

What is AstraZeneca's official website and social media links?

Minus sign iconPlus sign icon
AstraZeneca's official website is astrazeneca.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does AstraZeneca generate?

Minus sign iconPlus sign icon
As of October 2026, AstraZeneca's annual revenue is estimated to be $10B+.

What is AstraZeneca's SIC code and NAICS code?

Minus sign iconPlus sign icon
AstraZeneca's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AstraZeneca have currently?

Minus sign iconPlus sign icon
As of October 2026, AstraZeneca has approximately 82K employees across 6 continents, including Europe, North America and Asia. Key team members include Cfo: C. B., Cfo Ksa And Mea Strategic Initiatives Lead: M. A. and Coo - R&d Biopharma - Capacity Management Director: E. T. S. Explore AstraZeneca's employee directory with LeadIQ.

What industry does AstraZeneca belong to?

Minus sign iconPlus sign icon
AstraZeneca operates in the Pharmaceutical Manufacturing industry.

What technology does AstraZeneca use?

Minus sign iconPlus sign icon
AstraZeneca's tech stack includes Salesforce Lightning, Ansible, ChatGPT, Marketo, Oracle Eloqua, Webflow, Microsoft Azure and Cursor Code Editor.

What is AstraZeneca's email format?

Minus sign iconPlus sign icon
AstraZeneca's email format typically follows the pattern of First.Last@astrazeneca.com. Find more AstraZeneca email formats with LeadIQ.

How much funding has AstraZeneca raised to date?

Minus sign iconPlus sign icon
As of October 2026, AstraZeneca has raised $7.3B in funding. The last funding round occurred on Feb 25, 2026 for $1.5B.
AstraZeneca logo

AstraZeneca

Pharmaceutical ManufacturingEngland, United Kingdom10001+ Employees

AstraZeneca is a pharmaceutical manufacturing company headquartered in Cambridge, United Kingdom, with an address at 1 Francis Crick Avenue, Cambridge, CB2 0AA. It employs more than 10,000 people, reflecting a large-scale enterprise in the industry. The company engages in pharmaceutical development and manufacturing, applying scientific research to improve health outcomes and address broader societal and environmental considerations. Its official website is https://astrazeneca.com. Recent 2026 news references regulatory activity around its therapies, including regulatory submissions for Ultomiris and TRUQAP in the US.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
AZN
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $7.3B

    AstraZeneca has raised a total of $7.3B of funding over 4 rounds. Their latest funding round was raised on Feb 25, 2026 in the amount of $1.5B as a Post IPO Debt.

  • $10B+

    AstraZeneca's revenue is estimated to be in the range of $10B+

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.